Medtronic has acquired Crospon, an Irish med-tech company that makes tools for diagnosing gastrointestinal disorders. It is estimated that the deal could be worth as much as €38 million.
The US FDA has cleared Crospon’s Endoflip System for sale in the United System for the purpose of measuring and gauging pressure in the esophagus. The device aims to help healthcare practitioners diagnose motility disorders such as spasms in the intestine. Crospon has also developed a balloon catheter product called Esoflip.
Medtronic will integrate Crospon into its respiratory, gastrointestinal, and informatics division. With Crospon’s addition, Medtronic will have leading solutions from diagnosis to therapy for esophageal diseases.